242 related articles for article (PubMed ID: 36699022)
1. Structural homology between 11 beta-hydroxysteroid dehydrogenase and
Hernández-Bustamante I; Santander-Plantamura Y; Mata-Espinosa D; Reyes-Chaparro A; Bini EI; Torre-Villalvazo I; Tovar AR; Barrios-Payan J; Marquina-Castillo B; Hernández-Pando R; Carranza A
Front Endocrinol (Lausanne); 2022; 13():1055430. PubMed ID: 36699022
[TBL] [Abstract][Full Text] [Related]
2. 7α-hydroxylation of dehydroepiandrosterone does not interfere with the activation of glucocorticoids by 11β-hydroxysteroid dehydrogenase in E(t)C cerebellar neurons.
Gottfried-Blackmore A; Jellinck PH; Vecchiarelli HA; Masheeb Z; Kaufmann M; McEwen BS; Bulloch K
J Steroid Biochem Mol Biol; 2013 Nov; 138():290-7. PubMed ID: 23851218
[TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
[TBL] [Abstract][Full Text] [Related]
4. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes.
Hennebert O; Chalbot S; Alran S; Morfin R
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):326-33. PubMed ID: 17467270
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake.
McNelis JC; Manolopoulos KN; Gathercole LL; Bujalska IJ; Stewart PM; Tomlinson JW; Arlt W
Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1134-44. PubMed ID: 24022868
[TBL] [Abstract][Full Text] [Related]
7. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue.
Tagawa N; Minamitani E; Yamaguchi Y; Kobayashi Y
Steroids; 2011 Dec; 76(14):1546-53. PubMed ID: 21945397
[TBL] [Abstract][Full Text] [Related]
8. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
Ge R; Huang Y; Liang G; Li X
Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
[TBL] [Abstract][Full Text] [Related]
9. Inter-conversion of 7alpha- and 7beta-hydroxy-dehydroepiandrosterone by the human 11beta-hydroxysteroid dehydrogenase type 1.
Muller C; Pompon D; Urban P; Morfin R
J Steroid Biochem Mol Biol; 2006 Jun; 99(4-5):215-22. PubMed ID: 16603347
[TBL] [Abstract][Full Text] [Related]
10. Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids.
Nashev LG; Chandsawangbhuwana C; Balazs Z; Atanasov AG; Dick B; Frey FJ; Baker ME; Odermatt A
PLoS One; 2007 Jun; 2(6):e561. PubMed ID: 17593962
[TBL] [Abstract][Full Text] [Related]
11. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
13. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
[TBL] [Abstract][Full Text] [Related]
14. Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1.
Balázs Z; Nashev LG; Chandsawangbhuwana C; Baker ME; Odermatt A
Mol Cell Endocrinol; 2009 Mar; 301(1-2):117-22. PubMed ID: 19010388
[TBL] [Abstract][Full Text] [Related]
15. 16α-Bromoepiandrosterone as a new candidate for experimental diabetes-tuberculosis co-morbidity treatment.
López-Torres MO; Marquina-Castillo B; Ramos-Espinosa O; Mata-Espinosa D; Barrios-Payan JA; Baay-Guzman G; Yepez SH; Bini E; Torre-Villalvazo I; Torres N; Tovar A; Chamberlin W; Ge Y; Carranza A; Hernández-Pando R
Clin Exp Immunol; 2021 Aug; 205(2):232-245. PubMed ID: 33866550
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
Wang M
Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
[TBL] [Abstract][Full Text] [Related]
17. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
18. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR
Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
[TBL] [Abstract][Full Text] [Related]
19. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition.
Stimson RH; Andrew R; McAvoy NC; Tripathi D; Hayes PC; Walker BR
Diabetes; 2011 Mar; 60(3):720-5. PubMed ID: 21266326
[TBL] [Abstract][Full Text] [Related]
20. 11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases.
Kupczyk D; Bilski R; Kozakiewicz M; Studzińska R; Kędziora-Kornatowska K; Kosmalski T; Pedrycz-Wieczorska A; Głowacka M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
